NAVB - Retracement - MA Retest Coming UpNavidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
SHORT INTEREST
669.36K 09/13/19
P/E Current
-0.36
P/E Ratio (with extraordinary items)
-0.62
Average Recommendation: BUY
Average Target Price: 2.00
NAVB
NAVB pulse wave rise...The exchange rate is ahead of a significant increase. The target price for the first wave structure is 0.3785. This is a D1 ATR axis level. We expect a level of adjustment from this level, with a support level of 0.1700 usd. Then a double upward wave structure may develop with a target price of 0.5728.
NAVB GOING FOR ONE MORE WAVE UP?NAVB has broken the daily downward structure with a strong impulse. If it consolidates above this structure i'm expecting one more wave up. If it fails it is probably falling to the 0,60$ level.
